<code id='075759324A'></code><style id='075759324A'></style>
    • <acronym id='075759324A'></acronym>
      <center id='075759324A'><center id='075759324A'><tfoot id='075759324A'></tfoot></center><abbr id='075759324A'><dir id='075759324A'><tfoot id='075759324A'></tfoot><noframes id='075759324A'>

    • <optgroup id='075759324A'><strike id='075759324A'><sup id='075759324A'></sup></strike><code id='075759324A'></code></optgroup>
        1. <b id='075759324A'><label id='075759324A'><select id='075759324A'><dt id='075759324A'><span id='075759324A'></span></dt></select></label></b><u id='075759324A'></u>
          <i id='075759324A'><strike id='075759324A'><tt id='075759324A'><pre id='075759324A'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:comprehensive    Page View:1
          Paul Berggreen, a gastroenterologist at Arizona Digestive Health who formed a new lobbying group for independent physician practices. Arizona Digestive Health/ GI Alliance

          Private equity gets a bad rap in health care. But some doctors see that kind of cash and consolidation as the only way for their practices to survive — and now, they’re taking that message to Washington.

          Lower pay, difficult negotiations with insurance companies, regulatory requirements from both government and commercial payers, expensive and inefficient IT systems, and the challenge of competing against hospital systems have created a “cascade of problems that seem like they are almost insurmountable” for independent practices, said Paul Berggreen, a gastroenterologist at Arizona Digestive Health.

          advertisement

          Berggreen is joining with other doctors to start a lobbying group for private practices, the brand-new American Independent Medical Practice Association, or AIMPA, to fight against those problems and advocate for private practice physicians.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Hepatitis C has a cure — but many Americans still lack access to it
          Hepatitis C has a cure — but many Americans still lack access to it

          AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

          read more
          Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry
          Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

          GwenPetersen,38,anALSpatient,believesthattherecentfailureofAmylyx'sdrugRelyvriocouldstillteachresear

          read more
          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more

          Amid AI frenzy, a top HHS official's quest to create safeguards

          MickyTripathiOfficeoftheNationalCoordinatorforHealthInformationTechnologyMickyTripathiisequalpartsex